2m 2m 2m 2m 2m 2m 2m
Oncology Inst (TOI)
NASDAQ
$5.02-$0.01 (-0.20%)
Price as of Jun 23, 2026 7:58 PM EDT- $500.9MMarket Cap
- 114.04%1-Year Change
- Medical Care FacilitiesIndustry
Oncology Inst (TOI)
$5.02-$0.01 (-0.20%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 229.0M +11.77% | 204.9M -36.81% | 324.2M +28.42% | 252.5M +24.37% | |
Cost of Revenue | 205.5M +9.96% | 186.9M -29.39% | 264.7M +32.08% | 200.4M +23.58% | |
Gross Profit | 23.5M +30.47% | 18.0M -69.78% | 59.6M +14.36% | 52.1M +27.53% | |
Sales and Marketing Expense | 105.6M -2.09% | 107.8M -5.29% | 113.9M -4.88% | 119.7M +43.57% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 6.9M +10.45% | 6.3M +7.05% | 5.9M +33.14% | 4.4M +32.03% | |
Total Operating Expenses | 644.4M +14.79% | 561.4M +8.98% | 515.1M +13.43% | 454.1M +36.69% | |
Operating Profit | -36.1M -39.98% | -60.1M -21.94% | -77.0M -6.02% | -82.0M +78.71% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -6.8M +66.02% | -4.1M +1,175.63% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -6.8M +66.02% | -4.1M +1,175.63% | |
Total Nonoperating Income and Expense | -24.7M +442.44% | -4.5M -25.32% | -6.1M -107.43% | 81.9M +138.94% | |
Income before Taxes | -60.7M -6.07% | -64.7M -22.19% | -83.1M +91,223.08% | -91,000 -99.22% | |
Income Taxes | -131,000 N/A | 0 +100.00% | -36,000 -85.19% | -243,000 -63.79% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -60.6M -6.27% | -64.7M -22.16% | -83.1M -54,750.00% | 152,000 +101.39% | |
Net Income from Continuing Operations Applicable to Common | -50.3M -5.09% | -53.0M -21.91% | -67.9M +299.75% | -17.0M +46.40% | |
Basic EPS and Net Income | -0.54 -23.94% | -0.71 -22.83% | -0.92 N/A | 0.00 +100.00% | |
Diluted EPS and Net Income | -0.54 -23.94% | -0.71 -22.83% | -0.92 +338.10% | -0.21 +31.25% | |
Basic Weighted Average Shares | 92.4M +23.11% | 75.0M +1.76% | 73.7M +1.31% | 72.8M +9.91% | |
Diluted Weighted Average Shares | 92.4M +23.11% | 75.0M +1.76% | 73.7M -8.51% | 80.6M +21.70% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 33.6M -32.42% | 49.7M +48.32% | 33.5M +139.03% | 14.0M -87.84% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 49.4M -17.44% | 59.8M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 33.6M -32.42% | 49.7M -40.05% | 82.9M +12.26% | 73.8M -35.92% | |
Total Current Assets | 112.7M +0.29% | 112.4M -21.66% | 143.5M +10.03% | 130.4M -15.34% | |
Accumulated Depreciation | 10.9M +56.71% | 7.0M +12.82% | 6.2M +211.49% | 2.0M 0.00% | |
Property and Plant and Equipment and Net | 10.7M -10.13% | 11.9M +9.23% | 10.9M +27.33% | 8.5M +103.89% | |
Total Long-Term Assets | 606,000 +2.89% | 589,000 +4.99% | 561,000 +17.61% | 477,000 +49.06% | |
Total Assets | 164.7M -4.67% | 172.7M -17.46% | 209.2M -20.04% | 261.7M +28.62% | |
Income Taxes Payable | 0 -100.00% | 32,000 0.00% | 32,000 -91.18% | 363,000 -27.83% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 71.0M +35.90% | 52.2M +50.09% | 34.8M +17.05% | 29.7M -0.26% | |
Total Long-Term Debt | 77.4M -16.89% | 93.1M +7.26% | 86.8M +7.70% | 80.6M N/A | |
Total Long-Term Liabilities | 28,000 -77.60% | 125,000 -65.75% | 365,000 -57.95% | 868,000 -87.42% | |
Total Liabilities | 180.4M +6.65% | 169.1M +11.11% | 152.2M +9.91% | 138.5M +39.49% | |
Retained Earnings | -271.4M +28.75% | -210.8M +44.24% | -146.2M +131.68% | -63.1M -0.24% | |
Total Stockholders Equity | -15.7M -538.01% | 3.6M -93.71% | 57.0M -53.70% | 123.2M +18.26% | |
Total Shares Outstanding | 98.9M +30.53% | 75.7M +2.15% | 74.1M +1.20% | 73.3M +0.02% | |
Cash Flow | |||||
Cash from Operating Activities | -24.6M -7.35% | -26.5M -26.92% | -36.3M -41.20% | -61.8M +88.97% | |
Capital Expenditures | 3.2M -15.54% | 3.8M -17.04% | 4.6M -17.40% | 5.5M +94.20% | |
Cash from Investing Activities | -3.1M -106.65% | 46.2M -26.23% | 62.6M +147.59% | -131.6M +982.89% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.6M +430.96% | -3.5M -49.00% | -6.8M -107.43% | 92.2M -40.13% | |
Financials Ratio | |||||
Gross Margin | 10.26% +16.74% | 8.79% -52.17% | 18.37% -10.95% | 20.63% +2.54% | |
Operating Margin | -15.76% -46.30% | -29.34% +23.53% | -23.75% -26.82% | -32.46% +43.68% | |
Return on Assets | -35.93% +6.11% | -33.86% -4.03% | -35.28% -54,045.26% | 0.07% +101.30% | |
Return on Equity | 999.19% +568.31% | -213.36% +131.42% | -92.20% -69,056.84% | 0.13% +100.49% | |
Revenue Growth | 11.77% +131.97% | -36.81% -229.52% | 28.42% +16.60% | 24.37% N/A | |
Current Ratio | 1.59 -26.21% | 2.15 -47.80% | 4.12 -6.00% | 4.39 -15.12% | |
Cash Ratio | 0.47 -50.27% | 0.95 -1.18% | 0.96 +104.20% | 0.47 -87.80% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.65 +36,261.11% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.31 +34,133.33% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow